AJ

Active Director Director DIN 08077290
DIN 08077290 First appointment Mar 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2018
Shareholding value •••• Premium profile

About Anuj Jain

Data last updated:

Anuj Jain is a Director at Neonex Newborn Hospital Private Limited (since 2018). The company operates in Healthcare. Neonex Newborn Hospital Private Limited reported revenue of ₹1.73 Cr (FY 2024).

DIN 08077290
Primary Designation Director
Industry Healthcare
First Appointment 01 Mar 2018
Oldest Company Age 8 yrs
Largest company Neonex Newborn Hospital Private Limited · ₹1.73 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20182018₹1.73 Cr (FY 2024)Active

Board colleagues of Anuj Jain

NameDINCompanyDesignation
Nishant Bhalla08077289Neonex Newborn Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Neonex Newborn Hospital Private Limited
Premium access

Shareholding and investment profile for Anuj Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anuj Jain

Anuj Jain currently holds 1 directorship: Neonex Newborn Hospital Private Limited (Director, since 01 Mar 2018, revenue ₹1.73 Cr (FY 2024)).

Anuj Jain was first appointed on 01 Mar 2018 as Director at Neonex Newborn Hospital Private Limited.

The current boards of Anuj Jain's companies include Nishant Bhalla (Neonex Newborn Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available